Format

Send to:

Choose Destination
See comment in PubMed Commons below
Allerg Immunol (Paris). 2000 Mar;32(3):135-8.

New clinical data and therapeutic prospects in Cupressaceae pollen allergy.

Author information

  • 1Modulo d'Allergologia et Immunologia Clinica, Ospedale di Bordighera, IM, Italy.

Abstract

The authors emphasize, thanks to their clinical data over the last 20 years: The steady increase of allergy to C. sempervirens pollen compared to other pollinosis and to atopy. The frequency of cross-reactivity between C. sempervirens and other pollens belonging to Cupressaceae and Taxodiaceae families, in order, in the absence of a very good standardization and of a purification of this pollen, to try to undertake a sound specific immunotherapy using the most cross-reactive pollen mixed with C. sempervirens extracts. As a matter of fact the partially purified extracts of C. japonica gave the higher incidence (91%) of cross-reactivity. Consequently, a mixture of C. sempervirens and C. japonica extracts was used since 1993 with good results in a double blind study.

PMID:
10815250
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk